These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 36611906)

  • 1. The Long Telling Story of "Endothelial Progenitor Cells": Where Are We at Now?
    Vinci MC; Carulli E; Rurali E; Rinaldi R; Damiano G; Raucci A; Pompilio G; Genovese S
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise Review: Endothelial Progenitor Cells in Regenerative Medicine: Applications and Challenges.
    Chong MS; Ng WK; Chan JK
    Stem Cells Transl Med; 2016 Apr; 5(4):530-8. PubMed ID: 26956207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial progenitor cells participation in cardiovascular and kidney diseases: a systematic review.
    Kiewisz J; Kaczmarek MM; Pawlowska A; Kmiec Z; Stompor T
    Acta Biochim Pol; 2016; 63(3):475-82. PubMed ID: 27474403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Endothelial Progenitor Cell: Past, Present, and Future.
    Salybekov AA; Kobayashi S; Asahara T
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The State of Art of Regenerative Therapy in Cardiovascular Ischemic Disease: Biology, Signaling Pathways, and Epigenetics of Endothelial Progenitor Cells.
    Perrotta F; Perna A; Komici K; Nigro E; Mollica M; D'Agnano V; De Luca A; Guerra G
    Cells; 2020 Aug; 9(8):. PubMed ID: 32796767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are Endothelial Progenitor Cells the Real Solution for Cardiovascular Diseases? Focus on Controversies and Perspectives.
    Balistreri CR; Buffa S; Pisano C; Lio D; Ruvolo G; Mazzesi G
    Biomed Res Int; 2015; 2015():835934. PubMed ID: 26509164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Endothelial Progenitor Cells Biology and Regenerative Medicine in Pulmonary Vascular Diseases.
    Guerra G; Perrotta F; Testa G
    Curr Pharm Biotechnol; 2018; 19(9):700-707. PubMed ID: 30332949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of Endothelial Progenitor Cells: Summary and prospect.
    Yan F; Li J; Zhang W
    Acta Histochem; 2023 Jan; 125(1):151990. PubMed ID: 36587456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic targeting of endothelial progenitor cells.
    Albiero M; Menegazzo L; Avogaro A; Fadini GP
    Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):16-32. PubMed ID: 20100167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial progenitor cells as therapeutic agents in the microcirculation: an update.
    Napoli C; Hayashi T; Cacciatore F; Casamassimi A; Casini C; Al-Omran M; Ignarro LJ
    Atherosclerosis; 2011 Mar; 215(1):9-22. PubMed ID: 21126740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34 positive cells as endothelial progenitor cells in biology and medicine.
    Hassanpour M; Salybekov AA; Kobayashi S; Asahara T
    Front Cell Dev Biol; 2023; 11():1128134. PubMed ID: 37138792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High quality
    Mou Y; Yue Z; Zhang H; Shi X; Zhang M; Chang X; Gao H; Li R; Wang Z
    Int J Med Sci; 2017; 14(3):294-301. PubMed ID: 28367090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy.
    Bianconi V; Sahebkar A; Kovanen P; Bagaglia F; Ricciuti B; Calabrò P; Patti G; Pirro M
    Pharmacol Ther; 2018 Jan; 181():156-168. PubMed ID: 28827151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial Progenitor Cell-Derived Extracellular Vesicles: A Novel Candidate for Regenerative Medicine and Disease Treatment.
    Xing Z; Zhao C; Liu H; Fan Y
    Adv Healthc Mater; 2020 Jun; 9(12):e2000255. PubMed ID: 32378361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential use of endothelial progenitor cells for regeneration of the vasculature.
    Yamahara K; Itoh H
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):17-27. PubMed ID: 19144668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promise of autologous CD34+ stem/progenitor cell therapy for treatment of cardiovascular disease.
    Prasad M; Corban MT; Henry TD; Dietz AB; Lerman LO; Lerman A
    Cardiovasc Res; 2020 Jul; 116(8):1424-1433. PubMed ID: 32022845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial progenitor cells in regenerative medicine and cancer: a decade of research.
    Roncalli JG; Tongers J; Renault MA; Losordo DW
    Trends Biotechnol; 2008 May; 26(5):276-83. PubMed ID: 18359114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research and clinical applications regarding endothelial progenitor cell transplantation].
    Tan K; Sun X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 39(11):1211-6. PubMed ID: 25432379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Stem/Progenitor Cells as Prognostic Biomarkers in Macro- and Microvascular Disease: A Narrative Review of Prospective Observational Studies.
    Rigato M; Fadini GP
    Curr Med Chem; 2018; 25(35):4507-4517. PubMed ID: 28933297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial progenitor cells and cardiovascular disease.
    King TF; McDermott JH
    J Stem Cells; 2014; 9(2):93-106. PubMed ID: 25158158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.